ARTEC's technology is built upon patented methods for differentiating pluripotent stem cells into Natural Killer (NK) cells, as well as proprietary modifications of these NK cells to enhance their effectiveness in combating cancers. 

Information icon

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.